CA2366062A1 - Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations - Google Patents

Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations Download PDF

Info

Publication number
CA2366062A1
CA2366062A1 CA002366062A CA2366062A CA2366062A1 CA 2366062 A1 CA2366062 A1 CA 2366062A1 CA 002366062 A CA002366062 A CA 002366062A CA 2366062 A CA2366062 A CA 2366062A CA 2366062 A1 CA2366062 A1 CA 2366062A1
Authority
CA
Canada
Prior art keywords
seq
dkk
atcc
accession number
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002366062A
Other languages
English (en)
Other versions
CA2366062C (fr
Inventor
Sean Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2366062A1 publication Critical patent/CA2366062A1/fr
Application granted granted Critical
Publication of CA2366062C publication Critical patent/CA2366062C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne de nouveaux polypeptides, de nouvelles protéines et de nouvelles molécules d'acide nucléique Dkk et associées à Dkk. En plus de protéines Dkk et associées à Dkk isolées et complètes, l'invention concerne également des protéines de fusion isolées, des peptides antigéniques et des anticorps. L'invention concerne en outre des molécules d'acide nucléique Dkk et associées à Dkk, des vecteurs d'expression recombinants contenant une molécule d'acide nucléique de la présente invention, des cellules hôtes dans lesquelles on a introduit lesdits vecteurs d'expression et des animaux transgéniques non humains dans lesquels un gène Dkk ou associé à Dkk a été introduit ou dissocié. L'invention concerne par ailleurs des méthodes diagnostiques, thérapeutiques et de criblage qui utilisent les compositions de la présente invention.
CA2366062A 1999-03-05 2000-03-03 Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations Expired - Lifetime CA2366062C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26302299A 1999-03-05 1999-03-05
US09/263,022 1999-03-05
PCT/US2000/005452 WO2000052047A2 (fr) 1999-03-05 2000-03-03 Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations

Publications (2)

Publication Number Publication Date
CA2366062A1 true CA2366062A1 (fr) 2000-09-08
CA2366062C CA2366062C (fr) 2014-06-17

Family

ID=23000057

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2366062A Expired - Lifetime CA2366062C (fr) 1999-03-05 2000-03-03 Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations

Country Status (4)

Country Link
EP (1) EP1161445A2 (fr)
AU (1) AU3510200A (fr)
CA (1) CA2366062C (fr)
WO (1) WO2000052047A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001063295A2 (fr) * 2000-02-24 2001-08-30 Oxford Glycosciences (Uk) Ltd. Proteine dpi-6, cible therapeutique putative et biomarqueur pour les troubles neuropsychiatriques et neurologiques
EP1222933A1 (fr) * 2001-01-15 2002-07-17 Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum Génération et/ou réduction de nouveau tissu pulmonaire dans un poumon atteint, par modulation de la voie Wnt
HUP0303194A2 (hu) * 2001-02-16 2003-12-29 Genentech, Inc. DKK-1 és antagonistái alkalmazásai
EP1573024A4 (fr) 2001-04-10 2007-08-29 Agensys Inc Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
US20040038860A1 (en) 2002-05-17 2004-02-26 Allen Kristina M. Reagents and methods for modulating dkk-mediated interactions
CA2446582A1 (fr) * 2001-05-17 2002-11-21 Genome Therapeutics Corporation Reactifs et procedes destines a moduler des interactions induites par dkk
ES2304210B1 (es) * 2002-10-15 2009-09-28 Genentech, Inc Utilizacion de dkk-5, procedimiento y equipo de diagnostico de trastornos resistentes a la insulina e hibridoma y anticuerpo contra dkk-5.
US8124087B2 (en) 2002-12-05 2012-02-28 Board Of Trustees Of The University Of Arkansas Methods of controlling bone loss by inhibiting DKK1
US7811750B2 (en) * 2002-12-05 2010-10-12 Board Of Trustees Of The University Of Arkansas Molecular determinants of myeloma bone disease and use thereof
WO2004053063A2 (fr) * 2002-12-05 2004-06-24 The Board Of Trustees Of The University Of Arkansas System Determinants moleculaires de maladie osseuse de type myelome et utilisations de ceux-ci
US8637506B2 (en) * 2003-09-22 2014-01-28 Enzo Biochem, Inc. Compositions and methods for bone formation and remodeling
WO2005049797A2 (fr) * 2003-11-17 2005-06-02 Merck & Co., Inc. Proteine dickkopf-4 de macaque de buffon, nucleotides codant pour ladite proteine, et utilisations de cette proteine
WO2005049640A2 (fr) 2003-11-17 2005-06-02 Merck & Co., Inc. Proteine dickkopf-1 de singe rhesus, nucleotides codant ladite proteine, et procedes d'utilisation
US8343922B2 (en) * 2004-05-19 2013-01-01 Enzo Biochem, Inc. Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
WO2006010534A1 (fr) * 2004-07-28 2006-02-02 F.Hoffmann-La Roche Ag Dickkopf 3 en tant que cible / marqueur de la defaillance des cellules beta
EP2336177A1 (fr) 2004-08-04 2011-06-22 Amgen, Inc anticorps anti-DKK-1
EP1896495A2 (fr) 2005-03-30 2008-03-12 Novartis Vaccines and Diagnostics, Inc. Modulateurs de produit d'epissage de dkkl-1 pour diagnostic et therapie du cancer
WO2007104181A1 (fr) * 2006-03-13 2007-09-20 Shanghai Cancer Institute Utilisations de la protéine dkk-1 dans le diagnostic de cancers
EP2589658B1 (fr) 2010-07-01 2018-11-21 National University Corporation Okayama University Polypeptide de région partielle de la protéine reic/dkk-3
KR20130021315A (ko) * 2011-08-22 2013-03-05 인하대학교 산학협력단 Ｄｋｋ2 단백질 또는 그 유전자를 포함하는 발기부전 예방 또는 치료용 조성물 및 그의 용도
EP3990474A1 (fr) * 2019-06-25 2022-05-04 Friedrich Miescher Institute for Biomedical Research Promoteur pour l'expression spécifique de gènes dans des cellules exprimant une protéine acide fibrillaire gliale

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507227A (ja) * 1996-12-20 2001-06-05 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 小脳および胚に特異的なタンパク質
DK0975755T3 (da) * 1997-04-16 2007-06-11 Millennium Pharm Inc CRSP-protein (cysteinrige udskilte proteiner), nukleinsyremolekyler der koder herfor samt anvendelser deraf
DE19747418C1 (de) * 1997-10-27 1999-07-15 Deutsches Krebsforsch Inhibitor-Protein des wnt-Signalwegs
DE19844293C2 (de) * 1998-09-18 2002-03-14 B & S Elektronische Geraete Gm Beleuchtungseinrichtung

Also Published As

Publication number Publication date
CA2366062C (fr) 2014-06-17
WO2000052047A2 (fr) 2000-09-08
AU3510200A (en) 2000-09-21
WO2000052047A3 (fr) 2001-02-01
WO2000052047A9 (fr) 2002-03-14
EP1161445A2 (fr) 2001-12-12

Similar Documents

Publication Publication Date Title
US8202966B2 (en) Human Dickkopf-related protein and nucleic acid molecules and uses therefor
CA2366062C (fr) Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations
US20100093056A1 (en) Antibodies that bind dkk-related proteins
AU7137398A (en) Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
US5942420A (en) Molecules of the follistatin-related protein family and uses therefor
CA2292899A1 (fr) Element ntn-2 de la famille des ligands du tnf
MXPA01002461A (es) Genes inducidos por leptin.
AU784993B2 (en) CRSP protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
CA2351365A1 (fr) Proteines d'interaction de canaux potassiques (pcip) et procedes de leur utilisation
AU2013200856A1 (en) CRSP protein (Cysteine-Rich Secreted Proteins), nucleic acid molecules encoding them and uses thereof
AU2010236081A1 (en) CRSP protein (Cysteine-Rich Secreted Proteins), nucleic acid molecules encoding them and uses therefor

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200303